Philip Sasi

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 3

Top Topics

Sickle Cell Disease

Preterm Infants

Top Venues

Communications medicine

Antimicrobial agents and chemotherapy

This page only lists publications with an associated author ORCID identifier.

Publications

Philip Sasi, Abel Makubi, Raphael Zozimus Sangeda, Mariam Y Ngaeje, Bruno P Mmbando, Joseph Soka, Caterina Rosano, Alex S Magesa, Sharon E Cox, Julie Makani, Enrico M Novelli
Hydroxyurea mobile directly observed therapy versus standard monitoring in patients with sickle cell anemia: a phase 2 randomized trial. Communications medicine 4 (1) (2024)
Masanyiwa Ernest James, Helga Naburi, Sabina Mugusi, Peter P Kunambi, Tosi Mwakyandile, Rajabu Hussein Mnkugwe, Mohamed Ally Khalfan, Mainen J Moshi, Omary M Minzi, Philip Sasi
Gentamicin concentration and acute kidney injury in term neonates treated for neonatal sepsis with gentamicin and ampicillin-cloxacillin combination. Antimicrobial agents and chemotherapy (2024)
Philip Sasi, Abel Makubi, Raphael Zozimus Sangeda, Mariam Y Ngaeje, Bruno P Mmbando, Joseph Soka, Caterina Rosano, Alex S Magesa, Sharon E Cox, Julie Makani, Enrico M Novelli
Hydroxyurea mobile directly observed therapy versus standard monitoring in patients with sickle cell anemia: a phase 2 randomized trial. Communications medicine 4 (1) (2024)